Tedco awards $600K to tech firms - Austin Business Journal:

grachevakautawil.blogspot.com
The money was granted in collaboration withthe U.S. Army Medica l Research and Materiel Command and the througythe Ft. Detrick Technology Transfer Initiative. The purpose of the technologt transfer program is to raise awareness of new and developin technologies and funding them to transition as viabld projectsfor follow-on funding in the market place. Each companyh that received funding was awardefdapproximately $50,000 between March 2008 and May 2009, making up the initiative’s second round of financial award s since its $750,000 program The funds for the program’ss second phase were secured by Sen. Barbara Mikulski, D-Md., and Rep. Roscoe G. Bartlett, R-Md. “The [Ft.
Detrick Technology Transfer Initiative] programm is enabling area businesses to harness the technologiesd being developed at Fort Detrick and applyg them to thecommercial sector,” said “This will lead to new products that have the powedr to create jobs and save lives.” Mikulski announced the firsy phase of the tech transfer programk in March 2005 when 11 companies received in Rockville: The company is developing a healtg care technology called miTag system, whichg is a scalable wireless sensor solution for improving patient flow. in Frederick: The company is developing a technologu called the GeNova Screento identify, isolate, and producer antibody-like molecules.
in Rockville: The company is developing an on-demand biotech products including a combination vaccinre against plague and BioAssay Works LLCin Ijamsville: The company is developing a lateral-floww visual diagnostic test to detecty and differentiate single sample multiplwe pathogenic poxviruses, including variola, vaccinia, and in Catonsville: The company is safety-testing a medica product called ClotFoam, which is a intracavitary hemostatic agent.
CynerGene IDMP in The companyis developing, validating and implementinh a supplemental diagnosis of HIV, and Dengue using its Infectious Disease Multiplex Panekl approach, which could allow for creation of LLC in Baltimore: The companyg is developing required components and systej framework to enable conversationakl interfaces for telemedicine tools. Such tools woulr allow professional medics touse gesture, and other human-- computer interactionds to access and document information in electronicc medical records. in Rockville: The companuy is developing technology to preservw mammalian cells in dried format that can easilybe re-hydratex for a variety of uses.
LLC in Frederick: The compan is evaluating the effect of Imagilin patente d probiotics as a food supplement to enhance the immunse responsiveness of guinea pigs upon immunization or challengew withvirulent pathogens. The evaluation will sugges the ability of Imagilin patented probiotics to enhancr the immunization ofa vaccine. in The company is developinbg micropatterned substrates for viralinfectivity assays. Juxtopia in Baltimore: The companu is customizing its Wearable Assistance and SituationalAwareness (WASA) goggles and servicde to allow U.S.
Army combatr medics to access and document information to electrical medicao recordsvia hands-free voice-requests and in Baltimore: The company is developing cell therapies to treatt brain and spinal cord injuries.